5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.3 KiB
4.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | DRUG SUBSTITUTION-GENERICS | Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately. | us/states/il | Illinois General Assembly | 100th | HB 2531 | Illinois HB 2531 (100th) |
|
enacted | 3 | 26 | 2 | 2017-02-08 | 2017-08-11 | openstates | ocd-bill/6729efb8-cb3b-4fc1-90da-b966764389b0 | http://ilga.gov/legislation/BillStatus.asp?DocNum=2531&GAID=14&DocTypeID=HB&LegId=103711&SessionID=91&GA=100 | d7bc7f8e326d6499368e2b86b79c1d82f3280cb73d07f26f29c47a176e2e3cad | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Illinois HB 2531 (100th) — DRUG SUBSTITUTION-GENERICS
Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Third Reading — 110–0 (pass) · lower
- Third Reading — 53–0 (pass) · upper
Sponsors
- Norine K. Hammond — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-02-08 Filed with the Clerk by Rep. Norine K. Hammond
filing - 2017-02-08 First Reading
reading-1 - 2017-02-08 Referred to Rules Committee
referral-committee - 2017-02-22 Assigned to Human Services Committee
referral-committee - 2017-03-08 Do Pass / Short Debate Human Services Committee; 012-000-000
committee-passage - 2017-03-08 Placed on Calendar 2nd Reading - Short Debate
- 2017-03-09 Second Reading - Short Debate
reading-2 - 2017-03-09 Placed on Calendar Order of 3rd Reading - Short Debate
- 2017-03-15 Third Reading - Short Debate - Passed 110-000-000
reading-3, passage - 2017-03-15 Added Chief Co-Sponsor Rep. Patricia R. Bellock
- 2017-03-16 Arrive in Senate
introduction - 2017-03-16 Placed on Calendar Order of First Reading
reading-1 - 2017-03-16 Chief Senate Sponsor Sen. Jil Tracy
- 2017-03-16 First Reading
reading-1 - 2017-03-16 Referred to Assignments
referral-committee - 2017-04-25 Assigned to Public Health
referral-committee - 2017-05-03 Do Pass Public Health; 006-000-000
committee-passage - 2017-05-03 Placed on Calendar Order of 2nd Reading May 4, 2017
- 2017-05-12 Second Reading
reading-2 - 2017-05-12 Placed on Calendar Order of 3rd Reading May 15, 2017
- 2017-05-19 Third Reading - Passed; 053-000-000
reading-3, passage - 2017-05-19 Passed Both Houses
- 2017-06-16 Sent to the Governor
executive-receipt - 2017-08-11 Governor Approved
executive-signature - 2017-08-11 Effective Date August 11, 2017
- 2017-08-11 Public Act . . . . . . . . . 100-0065
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/6729efb8-cb3b-4fc1-90da-b966764389b0. Confidence: reported (aggregated from official Illinois legislature records).